The nucleic acid sequence of the 3' region of human T-cell leukemia virus type II (HTLV-II) proviral DNA was determined using a HTLV-I proviral clone that could be recovered as infectious, transforming virus. The sequence data indicate a region of unknown function of =1.6 kilobase pairs in the 3' region, analogous to the X region previously identified in human T-cell leukemia virus type I (HTLV-I). Three overlapping open reading frames are present in the X region of HTLV-II. One of these open reading frames, Xc, is most likely to encode a protein product, because it has greater predicted amino acid sequence homology (78%) with the X-IV region of HTLV-I and a greater percentage of its base differences with X-IV at the third nucleotide position of codons than do the other open reading frames. Sequences of the X-region that include the open reading frames are conserved in two deletion mutants of HTLV-II, which are associated with a subline of Mo cells with a decreased dependence on fetal bovine serum.
Human T-cell leukemia viruses (HTLV) are associated with certain forms of human leukemias and lymphomas (1) (2) (3) (4) (5) . At least two types of HTLV have been identified. HTLV type I (HTLV-I) is endemic to various regions of the world and is often associated with aggressive leukemias/lymphomas of mature T lymphocytes (3) (4) (5) . HTLV type II (HTLV-II) was found in a single patient (Mo) with a T-cell variant of hairycell leukemia (1, 2, 6 ). This patient is alive and well 8 yr after splenectomy.
Both HTLV-I and HTLV-TI transform normal human peripheral blood or cord blood T lymphocytes in vitro (7) (8) (9) (10) . These virus-transformed T cells have a helper-inducer phenotype similar to that of leukemic cells in patients with HTLV-associated disease. Elucidation of the mechanism of in vitro transformation is relevant to the process of leukemogenesis. However, the regions of the HTLV genome necessary for transformation have not been identified. Nucleic acid sequence analysis of the complete HTLV-I genome revealed a region at the 3' locus of the genome with no known function and without precedent in animal retroviruses other than bovine leukemia virus (11) . This region, referred to as X, is suspected to encode protein(s) involved in the process of transformation. The X region does not cross-hybridize with normal human cellular DNA sequences and, therefore, does not encode a retroviral oncogene.
HTLV-II has in vitro biological properties similar to but only limited homology with HTLV-I as determined by hybridization of the genomes and nucleic acid sequencing of the long terminal repeat (LTR) (12, 13) . By nucleic acid sequence analysis we have identified a region comparable to X in an infectious and transformation-competent molecular clone of HTLV-II. The homology between the two viruses in this region was determined.
MATERIALS AND METHODS
Sequencing of HTLV-II DNA. Bacterial plasmid pH6-B3.5, which contains env, X, and a part of the LTR of HTLV-II, was used as a source of DNA. pH6-B3.5 was subcloned from a cloned infectious HTLV-I provirus, XH6. The sequencing method of Maxam and Gilbert was applied to 5'-or 3'-endlabeled DNA fragments obtained by digestion of the DNA with restriction enzymes (14) . Both strands of the DNA were sequenced.
Comparison 
RESULTS
Nucleic Acid Sequence Analysis of the 3' Region of the HTLV-II Genome. Previous nucleic acid sequence analysis of HTLV-I revealed four potential open reading frames beginning with methionine codons in the 3' region of env (11) . However, as the sequenced provirus was not recovered as an infectious virus it may not represent the genome of a replication-and transformation-competent HTLV-I. Therefore, we first determined whether an apparently complete HTLV-II provirus clone, XH6, could be recovered as infectious virus capable of transforming normal human T lymphocytes.
Since HTLV-II can replicate in some B-lymphoblastoid cell lines, we used a B-cell line for HTLV-II DNA transfection. The HTLV-II provirus was subcloned into the plasmid vector pSV2-neo. Protoplasts of E. coli HB101 containing the HTLV-II subclone, pH6-neo (Fig. 1A) , were fused with WIL-2 cells and antibiotic G418-resistant clones of cells were subsequently selected. Of these G418-resistant B-cell clones, -25% expressed viral p19 and p24 antigens, as determined by indirect immunofluorescence (Fig. 1B) , and viral RNA which was correctly initiated from the cap site of the LTR (15) . These B cells were lethally irradiated and cocultivated with normal human peripheral blood lymphocytes as Abbreviations: HTLV-I and HTLV-II, human T-cell leukemia virus types I and II; LTR, long terminal repeat; kbp, kilobase pair(s).
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. described to test for HTLV-II transformation (10) . Cell lines with the T-helper surface-antigen phenotype were established and shown to be infected with HTLV-II. No B-cell markers (surface membrane immunoglobulin, Epstein-Barrvirus nuclear or capsid antigen) were detected in the transformed peripheral blood cells. The nucleic acid sequence of the XH6 provirus therefore represents the genome of a replication-and transformation-competent HTLV-II.
The nucleotide sequence of the 3' region of HTLV-II is shown in Fig. 2 ; env ends one base before the first nucleotide tive genome, typified by clone H9 (Fig. 4) , has a deletion of ly the entire internal sequence of HTLV-II. Furthermore, the deletion endpoints occur at the 5' end of the X region, upstream of the large open reading frames (Fig. 4) . DISCUSSION We have sequenced a 3' region of the HTLV-II genome of -1.6 kbp with an unknown function. HTLV-II resembles HTLV-I in a number of its properties, including biological functions, such as lymphoid target-cell specificity and T-cell transformation (1, 2, 6-10), and conservation of important structural features within the LTR (13) . The X region represents another common structural feature that is present in the genomes of both HTLV types. The X region of HTLV-II has 61% sequence homology with the X region of HTLV-I, and shows homology as great as 75% in the region encompassing the 3' two-thirds of the X region. The sequence conservation in this part of the X region in both types of HTLV strongly suggests that the X region serves though the predicted amino acid sequence of HTLV-II in these regions shows -60% homology with those of the X-II and X-III regions and 75% homology with that of the X-IV region of HTLV-I, the positions of initiation and termination codons would result in proteins of different predicted sizes.
Comparison of the LTR sequences of HTLV-II and HTLV-I indicates that these two viruses are only distantly related. It is likely that the two viruses evolved from a single ancestral virus and have retained common sequences that are important for replication (13) . Of the corresponding open reading frames in the two viral genomes, Xc and X-IV share the greatest sequence homology, the longest stretch of contiguous codons uninterrupted by termination codons, and the greatest frequency of third-position differences relative to first-and second-position differences. Therefore, it is likely that Xc in HTLV-II and X-IV in HTLV-I encode functional proteins.
The high predicted amino acid homology and relatively high frequency of third-position differences holds true for 112 codons in Xc/X-IV located upstream of the first methionine codon. Therefore, it is probable that Xc is translated as a fused protein from a spliced mRNA. In this regard, it is interesting to note that a potential splice acceptor site is lo- Since animal retroviruses for which nucleic acid sequence information is available do not have sequences comparable to the X region of HTLV, it is likely that this X region has a unique function in viral replication and cellular transformation. The retention of the open reading frames in the X region of the deletion mutants of HTLV-II may be relevant to that region's potential function in transformation, particularly since the deletion mutants are present only in a subline of the Mo cells having much less stringent growth requirements than the parental Mo cells. Identification of the proteins encoded by the X region and X-region-specific mRNAs will be necessary to determine the significance of the X region.
